Across TCGA pan-cancer cohorts, PRR14L Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated PRR14L data layer compared with 28 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher PRR14L Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated PRR14L expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC are the cancer types where PRR14L Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.982	0.822	.001	34	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: PRR14L tumor-vs-normal RNA expression · all PRR14L data types